UK markets closed

BRAIN Biotech AG (0RFI.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
2.8000-0.0845 (-2.93%)
At close: 01:11PM BST
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.31
52-week change 3-42.02%
S&P500 52-week change 326.14%
52-week high 36.9700
52-week low 30.0000
50-day moving average 34.9325
200-day moving average 34.9325

Share statistics

Avg vol (3-month) 39.58k
Avg vol (10-day) 310.81k
Shares outstanding 518.06M
Implied shares outstanding 6N/A
Float 89.09M
% held by insiders 160.62%
% held by institutions 113.93%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin -15.20%
Operating margin (ttm)-16.91%

Management effectiveness

Return on assets (ttm)-5.06%
Return on equity (ttm)-31.78%

Income statement

Revenue (ttm)55.23M
Revenue per share (ttm)2.53
Quarterly revenue growth (yoy)-7.20%
Gross profit (ttm)N/A
Net income avi to common (ttm)-8.39M
Diluted EPS (ttm)-0.3690
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.55M
Total cash per share (mrq)0.21
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)1.64
Book value per share (mrq)0.94

Cash flow statement

Operating cash flow (ttm)-4.82M
Levered free cash flow (ttm)-6.65M